Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nocardia rubra cell wall skeleton for erosive oral lichen planus (ChiCTR2100052030)
ChiCTR2100052030Phase 4Not yet recruiting
- Sponsor
- Peking University School and Hospital of Stomatology
- Start
- Nov 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of nocardia rubra cell wall skeleton in oral lichen planus (OLP) (2 arms), sponsored by Peking University School and Hospital of Stomatology. Primary endpoint: Visual analogue scale for oral pain. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
nocardia rubra cell wall skeleton
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on ChiCTR2100052030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052030.